Literature DB >> 15581208

Unchanged acetylation of isoniazid by alcohol intake.

J T R Wilcke1, M Døssing, H R Angelo, D Askgaard, A Rønn, H R Christensen.   

Abstract

SETTING: In 10 healthy subjects, the influence of acute alcohol intake on the pharmacokinetics of isoniazid (INH) was studied.
OBJECTIVE: To test the hypothesis that alcohol increases the conversion of INH by acetylation into its metabolite acetylisoniazid.
DESIGN: In a crossover design, an oral dose of 300 mg INH was administered on 2 separate days, 14 days apart, with or without alcohol to a serum alcohol of about 21 mmol/l (1 g/l) maintained for 12 h.
RESULTS: Neither the metabolism of INH nor that of acetylisoniazid was changed by acute alcohol intake.
CONCLUSION: Acute alcohol intake has no impact on the conversion of INH to its metabolite acetylisoniazid, which is catalysed by the enzyme N-acetyltranferase. Accordingly, a metabolic effect of acute alcohol intake on INH metabolism probably contributes little to the therapeutic failure of anti-tuberculosis treatment among alcoholics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581208

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  3 in total

1.  Is there any difference between acetylator phenotypes in tuberculosis patients and healthy subjects?

Authors:  Hossein Khalili; Simin Dashti-Khavidaki; Mohsen Amini; Reza Mahjub; Mahboobeh Hajiabdolbaghi
Journal:  Eur J Clin Pharmacol       Date:  2010-03       Impact factor: 2.953

2.  Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol.

Authors:  Bronwyn Myers; Tara C Bouton; Elizabeth J Ragan; Laura F White; Helen McIlleron; Danie Theron; Charles D H Parry; C Robert Horsburgh; Robin M Warren; Karen R Jacobson
Journal:  BMC Infect Dis       Date:  2018-09-29       Impact factor: 3.090

Review 3.  The Impact of Alcohol Use Disorder on Tuberculosis: A Review of the Epidemiology and Potential Immunologic Mechanisms.

Authors:  Gregory W Wigger; Tara C Bouton; Karen R Jacobson; Sara C Auld; Samantha M Yeligar; Bashar S Staitieh
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.